Molecular Tools: Biology, Prognosis, and Therapeutic Triage

被引:5
作者
Fischer, Ingeborg [1 ,2 ]
Aldape, Kenneth [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Unit 085, Houston, TX 77030 USA
[2] Univ Zurich Hosp, Dept Neuropathol, CH-8091 Zurich, Switzerland
关键词
Glioma; Malignant tumor; Targeted therapy; Molecular; Genetic; GROWTH-FACTOR-RECEPTOR; PHASE-II TRIAL; RECURRENT GLIOBLASTOMA-MULTIFORME; BEVACIZUMAB PLUS IRINOTECAN; TYROSINE KINASE INHIBITOR; HUMAN-MALIGNANT GLIOMAS; TGF-BETA; GENETIC ALTERATIONS; 1P/19Q LOSS; ANAPLASTIC OLIGODENDROGLIOMAS;
D O I
10.1016/j.nic.2010.05.004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Diffuse gliomas in adults continue to have a dismal prognosis with the current standard therapeutic methods, including maximal surgical resection, radiation, and chemotherapy. The pathogenesis of adult glioma is complex, involving the loss of function of tumor suppressor genes and activation of oncogenes, which are involved in a network of interconnected signaling pathways. Through activation of these pathways, characteristics of malignant gliomas, including uncontrolled proliferation and growth, invasion, and angiogenesis, are driven. Evolving therapeutic approaches are focused on specifically targeting these genetic lesions. This content gives an overview of the current knowledge about the pathogenesis of adult diffuse gliomas, emphasizing new targeted treatment approaches.
引用
收藏
页码:273 / +
页数:11
相关论文
共 92 条
[1]   Survey of treatment recommendations for anaplastic oligodendroglioma [J].
Abrey, Lauren E. ;
Louis, David N. ;
Paleologos, Nina ;
Lassman, Andrew B. ;
Raizer, Jeffrey J. ;
Mason, Warren ;
Finlay, Jonathan ;
MacDonald, David R. ;
DeAngelis, Lisa M. ;
Cairncross, J. Gregory .
NEURO-ONCOLOGY, 2007, 9 (03) :314-318
[2]   Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27(KIP1) [J].
Aktas, H ;
Cai, H ;
Cooper, GM .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (07) :3850-3857
[3]  
Aldape K, 2007, ARCH PATHOL LAB MED, V131, P242
[4]   AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients [J].
Batchelor, Tracy T. ;
Sorensen, A. Gregory ;
di Tomaso, Emmanuelle ;
Zhang, Wei-Ting ;
Duda, Dan G. ;
Cohen, Kenneth S. ;
Kozak, Kevin R. ;
Cahill, Daniel P. ;
Chen, Poe-Jou ;
Zhu, Mingwang ;
Ancukiewicz, Marek ;
Mrugala, Maciej M. ;
Plotkin, Scott ;
Drappatz, Jan ;
Louis, David N. ;
Ivy, Percy ;
Scadden, David T. ;
Benner, Thomas ;
Loeffler, Jay S. ;
Wen, Patrick Y. ;
Jain, Rakesh K. .
CANCER CELL, 2007, 11 (01) :83-95
[5]   Long term responses with cetuximab therapy in glioblastoma multiforme [J].
Belda-Iniesta, Cristobal ;
de Castro Carpeno, Javier ;
Casado Saenz, Enrique ;
Gutierrez, Manuel ;
Perona, Rosario ;
Gonzalez Baron, Manuel .
CANCER BIOLOGY & THERAPY, 2006, 5 (08) :912-914
[6]   Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population [J].
Brat, DJ ;
Castellano-Sanchez, AA ;
Hunter, SB ;
Pecot, M ;
Cohen, C ;
Hammond, EH ;
Devi, SN ;
Kaur, B ;
Van Meir, EG .
CANCER RESEARCH, 2004, 64 (03) :920-927
[7]   Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas [J].
Cairncross, JG ;
Ueki, K ;
Zlatescu, MC ;
Lisle, DK ;
Finkelstein, DM ;
Hammond, RR ;
Silver, JS ;
Stark, PC ;
Macdonald, DR ;
Ino, Y ;
Ramsay, DA ;
Louis, DN .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (19) :1473-1479
[8]   The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas [J].
Chakravarti, A ;
Zhai, G ;
Suzuki, Y ;
Sarkesh, S ;
Black, PM ;
Muzikansky, A ;
Loeffler, JS .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) :1926-1933
[9]   Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma [J].
Chan, ASY ;
Leung, SY ;
Wong, MP ;
Yuen, ST ;
Cheung, N ;
Fan, YW ;
Chung, LP .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (07) :816-826
[10]   Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor [J].
Cheng, SY ;
Huang, HJS ;
Nagane, M ;
Ji, XD ;
Wang, DG ;
Shih, CCY ;
Arap, W ;
Huang, CM ;
Cavenee, WK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) :8502-8507